SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-20-000119
Filing Date
2020-02-12
Accepted
2020-02-12 19:24:36
Documents
1
Period of Report
2020-02-10

Document Format Files

Seq Description Document Type Size
1 biopharmx_fm4feb102020.html 4  
1 biopharmx_fm4feb102020.xml 4 8305
  Complete submission text file 0000905718-20-000119.txt   9905
Mailing Address 115 NICHOLSON LANE SAN JOSE CA 95134
Business Address 115 NICHOLSON LANE SAN JOSE CA 95134 650-889-5020
BioPharmX Corp (Issuer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
SIC: 2834 Pharmaceutical Preparations

Mailing Address 50 TICE BOULEVARD, SUITE A26 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE A26 WOODCLIFF LAKE NJ 07677 201-645-4767
TardiMed Sciences LLC (Reporting) CIK: 0001800690 (see all company filings)

State of Incorp.: CT | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37411 | Film No.: 20606428